Reactogenicity and immunogenicity of inactivated hepatitis A vaccines.
Vaccine
; 10 Suppl 1: S110-3, 1992.
Article
em En
| MEDLINE
| ID: mdl-1362031
ABSTRACT
Two inactivated hepatitis A virus (HAV) candidate vaccine strain were tested, derived from strains CLF and HM175. Neither vaccine increased liver enzymes levels and reactogenicity was similar to that observed with other alum-absorbed products. Antibody responses were dose-dependent and protection against HAV can be presumed to last for at least three years. All persons receiving 720 ELISA units (El.U) of the CLF vaccine seroconverted after one dose. For the HM175 vaccine, anti-HAV persisted until month 12 after injections at months 0 and 1, suggesting that the third dose of vaccine could be given at any time from month 6 to 12. A double dose of HM175 vaccine (1440 El.U) given as a single bolus resulted in 100% seroconversion by day 14 with a geometric mean anti-HAV level of 121 mIU/ml. This implies that rapid protection can be induced using large doses of inactivated HAV vaccine should time constraints dictate such an approach.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Vacinas contra Hepatite Viral
/
Anticorpos Anti-Hepatite
/
Hepatovirus
Tipo de estudo:
Clinical_trials
País/Região como assunto:
Europa
Idioma:
En
Revista:
Vaccine
Ano de publicação:
1992
Tipo de documento:
Article
País de afiliação:
Suíça